Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years. Biomol Biomed [Internet]. 2021 Oct. 1 [cited 2025 Mar. 10];21(5):620-31. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/5271